Missense Variant rs28362680 in BTNL2 Reduces Risk of Coronary Heart Disease

Jian Zhuo1 Department of Emergency Service, People’s Hospital of Wanning, Wanning, Hainan, 571500, People’s Republic of ChinaView further author information

Yingchun Wu2 Department of Intensive Care Unit, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, People’s Republic of ChinaView further author information

Wei Li1 Department of Emergency Service, People’s Hospital of Wanning, Wanning, Hainan, 571500, People’s Republic of ChinaView further author information

Zerong Li1 Department of Emergency Service, People’s Hospital of Wanning, Wanning, Hainan, 571500, People’s Republic of ChinaView further author information

Yipeng Ding3 Department of General Practice, Hainan General Hospital, Hainan affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-6636-5155 View further author information

Tianbo Jin4 Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi‘an, Shaanxi, 710069, People’s Republic of China;5 Provincial Key Laboratory of Biotechnology of Shaanxi Province, Northwest University, Xi’an, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Missense Variant rs28362680 in BTNL2 Reduces Risk of Coronary Heart Disease

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Missense Variant rs28362680 in BTNL2 Reduces Risk of Coronary Heart Disease

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date